Report Store mobile icon
Global Plasma Fractionation Market Growth 2024-2030
Global Plasma Fractionation Market Growth 2024-2030

2024

Global Plasma Fractionation Market Growth 2024-2030

Plasma Fractionation market rises from US$27.49 billion in 2023 to US$46.76 billion by 2030, with a 7.9% CAGR, due to increasing demand in the downstream market.

Buy Now Get Free sample

New Report Guarantee

If you purchase this report now and we update it in new 100 days, get it free!

Blood plasma, the liquid portion of blood, is a life-giving resource. Within its straw-colored depths lies a treasure trove of proteins, numbering in the thousands, each playing a vital role in maintaining health. The global blood plasma fractionation market capitalizes on this potential, transforming donated plasma into a powerful tool for treating a multitude of diseases. Plasma is akin to the body's internal river system, transporting nutrients, hormones, and waste products throughout the body. But its most valuable cargo is a collection of proteins, some well-known like albumin and globulins, and others waiting to be fully explored. These proteins are the workhorses of our immune system, the architects of blood clots, and the transport vehicles for delivering oxygen and nutrients to our cells. They act as enzymes speeding up vital biochemical reactions, and even help regulate fluid balance in our tissues. According to our publisher’s latest study, the global Plasma Fractionation market size was valued at US$ 27490 million in 2023. With growing demand in downstream market, the Plasma Fractionation is forecast to a readjusted size of US$ 46760 million by 2030 with a CAGR of 7.9% during review period. The research report highlights the growth potential of the global Plasma Fractionation market. Plasma Fractionation are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Plasma Fractionation. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Plasma Fractionation market.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation. Global Plasma Fractionation key players include Takeda, CSL, Grifols, Octapharma, Kedrion, etc. Global top five manufacturers hold a share about 75%. North America is the largest market, with a share over 40%, followed by Europe and China, both have a share about 40 percent. In terms of product, Immune Globulin is the largest segment, with a share about 50%. And in terms of application, the largest application is Immunology, followed by Hematology. Key Features:

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

The report on Plasma Fractionation market reflects various aspects and provide valuable insights into the industry. Market Size and Growth: The research report provide an overview of the current size and growth of the Plasma Fractionation market. It may include historical data, market segmentation by Type (e.g., Albumin, Immune Globulin), and regional breakdowns. Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Plasma Fractionation market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Market Drivers: • Disease Burden: Rising prevalence of chronic illnesses like immunodeficiencies and hemophilia fuels demand for plasma-derived therapies. • Aging Population: As populations age, the need for these treatments to address weakened immune systems is expected to climb. Market Trends: • Technological Advancements: Improved fractionation techniques are leading to purer, more effective plasma-derived products. • Emerging Market Focus: Developing economies with growing healthcare infrastructure are presenting new opportunities for market expansion. Market Challenges: • Plasma Shortage: The global demand for plasma often outpaces the readily available supply, especially in developing regions. • High Costs: Developing, manufacturing, and storing plasma-derived therapies can be expensive, limiting access in some areas. Competitive Landscape: The research report provides analysis of the competitive landscape within the Plasma Fractionation market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market. Technological Developments: The research report can delve into the latest technological developments in the Plasma Fractionation industry. This include advancements in Plasma Fractionation technology, Plasma Fractionation new entrants, Plasma Fractionation new investment, and other innovations that are shaping the future of Plasma Fractionation. • Precision Fractionation: New techniques like chromatography and membrane filtration are improving the purity and yield of isolated proteins, leading to more potent and targeted therapies. • Viral Inactivation Methods: Enhanced viral inactivation methods like solvent/detergent treatment and nanofiltration ensure the safety and efficacy of plasma-derived products. • Automation on the Rise: Automation in plasma collection and processing is streamlining operations, increasing efficiency, and potentially reducing costs. Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Plasma Fractionation market. It includes factors influencing customer ' purchasing decisions, preferences for Plasma Fractionation product. Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Plasma Fractionation market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Plasma Fractionation market. The report also evaluates the effectiveness of these policies in driving market growth. Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Plasma Fractionation market. Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Plasma Fractionation industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments. • Rising Demand: Growing prevalence of chronic diseases and an aging population will increase the need for plasma-derived therapies. • Technological Advancements: Innovations in fractionation techniques will improve product yield, purity, and potentially unlock new applications. • Emerging Market Boom: Developing economies with expanding healthcare infrastructure present significant growth potential. Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Plasma Fractionation market. • Combatting Chronic Diseases: Rising prevalence of conditions like immunodeficiencies creates demand for plasma-derived therapies as crucial weapons in the fight. • Aging Advantage: An aging population translates to a growing need for these therapies to treat age-related conditions affecting the immune system. • Tech Triumphs: Advancements in fractionation techniques promise improved yields and purer plasma products, enhancing their effectiveness. Market Segmentation: Plasma Fractionation market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. Segmentation by type Albumin Immune Globulin Coagulation Factor Others Segmentation by application Immunology Hematology Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Takeda CSL Grifols Octapharma Kedrion LFB Group Biotest BPL RAAS CBPO

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Plasma Fractionation Annual Sales 2019-2030
  • 2.1.2 World Current & Future Analysis for Plasma Fractionation by Geographic Region, 2019, 2023 & 2030
  • 2.1.3 World Current & Future Analysis for Plasma Fractionation by Country/Region, 2019, 2023 & 2030
  • 2.2 Plasma Fractionation Segment by Type
  • 2.2.1 Albumin
  • 2.2.2 Immune Globulin
  • 2.2.3 Coagulation Factor
  • 2.2.4 Others
  • 2.3 Plasma Fractionation Sales by Type
  • 2.3.1 Global Plasma Fractionation Sales Market Share by Type (2019-2024)
  • 2.3.2 Global Plasma Fractionation Revenue and Market Share by Type (2019-2024)
  • 2.3.3 Global Plasma Fractionation Sale Price by Type (2019-2024)
  • 2.4 Plasma Fractionation Segment by Application
  • 2.4.1 Immunology
  • 2.4.2 Hematology
  • 2.4.3 Others
  • 2.5 Plasma Fractionation Sales by Application
  • 2.5.1 Global Plasma Fractionation Sale Market Share by Application (2019-2024)
  • 2.5.2 Global Plasma Fractionation Revenue and Market Share by Application (2019-2024)
  • 2.5.3 Global Plasma Fractionation Sale Price by Application (2019-2024)
  • 3 Global Plasma Fractionation by Company
  • 3.1 Global Plasma Fractionation Breakdown Data by Company
  • 3.1.1 Global Plasma Fractionation Annual Sales by Company (2019-2024)
  • 3.1.2 Global Plasma Fractionation Sales Market Share by Company (2019-2024)
  • 3.2 Global Plasma Fractionation Annual Revenue by Company (2019-2024)
  • 3.2.1 Global Plasma Fractionation Revenue by Company (2019-2024)
  • 3.2.2 Global Plasma Fractionation Revenue Market Share by Company (2019-2024)
  • 3.3 Global Plasma Fractionation Sale Price by Company
  • 3.4 Key Manufacturers Plasma Fractionation Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Plasma Fractionation Product Location Distribution
  • 3.4.2 Players Plasma Fractionation Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Plasma Fractionation by Geographic Region
  • 4.1 World Historic Plasma Fractionation Market Size by Geographic Region (2019-2024)
  • 4.1.1 Global Plasma Fractionation Annual Sales by Geographic Region (2019-2024)
  • 4.1.2 Global Plasma Fractionation Annual Revenue by Geographic Region (2019-2024)
  • 4.2 World Historic Plasma Fractionation Market Size by Country/Region (2019-2024)
  • 4.2.1 Global Plasma Fractionation Annual Sales by Country/Region (2019-2024)
  • 4.2.2 Global Plasma Fractionation Annual Revenue by Country/Region (2019-2024)
  • 4.3 Americas Plasma Fractionation Sales Growth
  • 4.4 APAC Plasma Fractionation Sales Growth
  • 4.5 Europe Plasma Fractionation Sales Growth
  • 4.6 Middle East & Africa Plasma Fractionation Sales Growth
  • 5 Americas
  • 5.1 Americas Plasma Fractionation Sales by Country
  • 5.1.1 Americas Plasma Fractionation Sales by Country (2019-2024)
  • 5.1.2 Americas Plasma Fractionation Revenue by Country (2019-2024)
  • 5.2 Americas Plasma Fractionation Sales by Type
  • 5.3 Americas Plasma Fractionation Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Plasma Fractionation Sales by Region
  • 6.1.1 APAC Plasma Fractionation Sales by Region (2019-2024)
  • 6.1.2 APAC Plasma Fractionation Revenue by Region (2019-2024)
  • 6.2 APAC Plasma Fractionation Sales by Type
  • 6.3 APAC Plasma Fractionation Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe Plasma Fractionation by Country
  • 7.1.1 Europe Plasma Fractionation Sales by Country (2019-2024)
  • 7.1.2 Europe Plasma Fractionation Revenue by Country (2019-2024)
  • 7.2 Europe Plasma Fractionation Sales by Type
  • 7.3 Europe Plasma Fractionation Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Plasma Fractionation by Country
  • 8.1.1 Middle East & Africa Plasma Fractionation Sales by Country (2019-2024)
  • 8.1.2 Middle East & Africa Plasma Fractionation Revenue by Country (2019-2024)
  • 8.2 Middle East & Africa Plasma Fractionation Sales by Type
  • 8.3 Middle East & Africa Plasma Fractionation Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Plasma Fractionation
  • 10.3 Manufacturing Process Analysis of Plasma Fractionation
  • 10.4 Industry Chain Structure of Plasma Fractionation
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 Plasma Fractionation Distributors
  • 11.3 Plasma Fractionation Customer
  • 12 World Forecast Review for Plasma Fractionation by Geographic Region
  • 12.1 Global Plasma Fractionation Market Size Forecast by Region
  • 12.1.1 Global Plasma Fractionation Forecast by Region (2025-2030)
  • 12.1.2 Global Plasma Fractionation Annual Revenue Forecast by Region (2025-2030)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Plasma Fractionation Forecast by Type
  • 12.7 Global Plasma Fractionation Forecast by Application
  • 13 Key Players Analysis
  • 13.1 Takeda
  • 13.1.1 Takeda Company Information
  • 13.1.2 Takeda Plasma Fractionation Product Portfolios and Specifications
  • 13.1.3 Takeda Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.1.4 Takeda Main Business Overview
  • 13.1.5 Takeda Latest Developments
  • 13.2 CSL
  • 13.2.1 CSL Company Information
  • 13.2.2 CSL Plasma Fractionation Product Portfolios and Specifications
  • 13.2.3 CSL Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.2.4 CSL Main Business Overview
  • 13.2.5 CSL Latest Developments
  • 13.3 Grifols
  • 13.3.1 Grifols Company Information
  • 13.3.2 Grifols Plasma Fractionation Product Portfolios and Specifications
  • 13.3.3 Grifols Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.3.4 Grifols Main Business Overview
  • 13.3.5 Grifols Latest Developments
  • 13.4 Octapharma
  • 13.4.1 Octapharma Company Information
  • 13.4.2 Octapharma Plasma Fractionation Product Portfolios and Specifications
  • 13.4.3 Octapharma Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.4.4 Octapharma Main Business Overview
  • 13.4.5 Octapharma Latest Developments
  • 13.5 Kedrion
  • 13.5.1 Kedrion Company Information
  • 13.5.2 Kedrion Plasma Fractionation Product Portfolios and Specifications
  • 13.5.3 Kedrion Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.5.4 Kedrion Main Business Overview
  • 13.5.5 Kedrion Latest Developments
  • 13.6 LFB Group
  • 13.6.1 LFB Group Company Information
  • 13.6.2 LFB Group Plasma Fractionation Product Portfolios and Specifications
  • 13.6.3 LFB Group Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.6.4 LFB Group Main Business Overview
  • 13.6.5 LFB Group Latest Developments
  • 13.7 Biotest
  • 13.7.1 Biotest Company Information
  • 13.7.2 Biotest Plasma Fractionation Product Portfolios and Specifications
  • 13.7.3 Biotest Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.7.4 Biotest Main Business Overview
  • 13.7.5 Biotest Latest Developments
  • 13.8 BPL
  • 13.8.1 BPL Company Information
  • 13.8.2 BPL Plasma Fractionation Product Portfolios and Specifications
  • 13.8.3 BPL Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.8.4 BPL Main Business Overview
  • 13.8.5 BPL Latest Developments
  • 13.9 RAAS
  • 13.9.1 RAAS Company Information
  • 13.9.2 RAAS Plasma Fractionation Product Portfolios and Specifications
  • 13.9.3 RAAS Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.9.4 RAAS Main Business Overview
  • 13.9.5 RAAS Latest Developments
  • 13.10 CBPO
  • 13.10.1 CBPO Company Information
  • 13.10.2 CBPO Plasma Fractionation Product Portfolios and Specifications
  • 13.10.3 CBPO Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.10.4 CBPO Main Business Overview
  • 13.10.5 CBPO Latest Developments
  • 13.11 Hualan Bio
  • 13.11.1 Hualan Bio Company Information
  • 13.11.2 Hualan Bio Plasma Fractionation Product Portfolios and Specifications
  • 13.11.3 Hualan Bio Plasma Fractionation Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.11.4 Hualan Bio Main Business Overview
  • 13.11.5 Hualan Bio Latest Developments
  • 14 Research Findings and Conclusion

List of Tables
Table 1. Plasma Fractionation Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Plasma Fractionation Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Albumin
Table 4. Major Players of Immune Globulin
Table 5. Major Players of Coagulation Factor
Table 6. Major Players of Others
Table 7. Global Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 8. Global Plasma Fractionation Sales Market Share by Type (2019-2024)
Table 9. Global Plasma Fractionation Revenue by Type (2019-2024) & ($ million)
Table 10. Global Plasma Fractionation Revenue Market Share by Type (2019-2024)
Table 11. Global Plasma Fractionation Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 13. Global Plasma Fractionation Sales Market Share by Application (2019-2024)
Table 14. Global Plasma Fractionation Revenue by Application (2019-2024)
Table 15. Global Plasma Fractionation Revenue Market Share by Application (2019-2024)
Table 16. Global Plasma Fractionation Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Plasma Fractionation Sales by Company (2019-2024) & (K Units)
Table 18. Global Plasma Fractionation Sales Market Share by Company (2019-2024)
Table 19. Global Plasma Fractionation Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Plasma Fractionation Revenue Market Share by Company (2019-2024)
Table 21. Global Plasma Fractionation Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Plasma Fractionation Producing Area Distribution and Sales Area
Table 23. Players Plasma Fractionation Products Offered
Table 24. Plasma Fractionation Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Plasma Fractionation Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Plasma Fractionation Sales Market Share Geographic Region (2019-2024)
Table 29. Global Plasma Fractionation Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Plasma Fractionation Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Plasma Fractionation Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Plasma Fractionation Sales Market Share by Country/Region (2019-2024)
Table 33. Global Plasma Fractionation Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Plasma Fractionation Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Plasma Fractionation Sales by Country (2019-2024) & (K Units)
Table 36. Americas Plasma Fractionation Sales Market Share by Country (2019-2024)
Table 37. Americas Plasma Fractionation Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Plasma Fractionation Revenue Market Share by Country (2019-2024)
Table 39. Americas Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 40. Americas Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 41. APAC Plasma Fractionation Sales by Region (2019-2024) & (K Units)
Table 42. APAC Plasma Fractionation Sales Market Share by Region (2019-2024)
Table 43. APAC Plasma Fractionation Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Plasma Fractionation Revenue Market Share by Region (2019-2024)
Table 45. APAC Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 46. APAC Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 47. Europe Plasma Fractionation Sales by Country (2019-2024) & (K Units)
Table 48. Europe Plasma Fractionation Sales Market Share by Country (2019-2024)
Table 49. Europe Plasma Fractionation Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Plasma Fractionation Revenue Market Share by Country (2019-2024)
Table 51. Europe Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 52. Europe Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Plasma Fractionation Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Plasma Fractionation Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Plasma Fractionation Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Plasma Fractionation Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Plasma Fractionation Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Plasma Fractionation Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Plasma Fractionation
Table 60. Key Market Challenges & Risks of Plasma Fractionation
Table 61. Key Industry Trends of Plasma Fractionation
Table 62. Plasma Fractionation Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Plasma Fractionation Distributors List
Table 65. Plasma Fractionation Customer List
Table 66. Global Plasma Fractionation Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Plasma Fractionation Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Plasma Fractionation Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Plasma Fractionation Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Plasma Fractionation Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Plasma Fractionation Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Plasma Fractionation Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Plasma Fractionation Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Plasma Fractionation Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Plasma Fractionation Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Plasma Fractionation Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Plasma Fractionation Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Plasma Fractionation Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Plasma Fractionation Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Takeda Basic Information, Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 81. Takeda Plasma Fractionation Product Portfolios and Specifications
Table 82. Takeda Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Takeda Main Business
Table 84. Takeda Latest Developments
Table 85. CSL Basic Information, Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 86. CSL Plasma Fractionation Product Portfolios and Specifications
Table 87. CSL Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. CSL Main Business
Table 89. CSL Latest Developments
Table 90. Grifols Basic Information, Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 91. Grifols Plasma Fractionation Product Portfolios and Specifications
Table 92. Grifols Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Grifols Main Business
Table 94. Grifols Latest Developments
Table 95. Octapharma Basic Information, Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 96. Octapharma Plasma Fractionation Product Portfolios and Specifications
Table 97. Octapharma Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Octapharma Main Business
Table 99. Octapharma Latest Developments
Table 100. Kedrion Basic Information, Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 101. Kedrion Plasma Fractionation Product Portfolios and Specifications
Table 102. Kedrion Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Kedrion Main Business
Table 104. Kedrion Latest Developments
Table 105. LFB Group Basic Information, Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 106. LFB Group Plasma Fractionation Product Portfolios and Specifications
Table 107. LFB Group Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. LFB Group Main Business
Table 109. LFB Group Latest Developments
Table 110. Biotest Basic Information, Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 111. Biotest Plasma Fractionation Product Portfolios and Specifications
Table 112. Biotest Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Biotest Main Business
Table 114. Biotest Latest Developments
Table 115. BPL Basic Information, Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 116. BPL Plasma Fractionation Product Portfolios and Specifications
Table 117. BPL Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. BPL Main Business
Table 119. BPL Latest Developments
Table 120. RAAS Basic Information, Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 121. RAAS Plasma Fractionation Product Portfolios and Specifications
Table 122. RAAS Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. RAAS Main Business
Table 124. RAAS Latest Developments
Table 125. CBPO Basic Information, Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 126. CBPO Plasma Fractionation Product Portfolios and Specifications
Table 127. CBPO Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. CBPO Main Business
Table 129. CBPO Latest Developments
Table 130. Hualan Bio Basic Information, Plasma Fractionation Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Bio Plasma Fractionation Product Portfolios and Specifications
Table 132. Hualan Bio Plasma Fractionation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Hualan Bio Main Business
Table 134. Hualan Bio Latest Developments

Related Tags

Related Reports

payment cards

Allows one individual to access the purchased report Read More

Allows all employees of an organization to access the purchased report. Internal sharing only Read More

Allows all employees of an organization to access the purchased report. It also permits the use of up to 4 paragraphs or 1 page of the report externally in whitepapers, press releases, and marketing collateral Read More

Buy Now

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Rishika Gupta

Rishika Gupta

Team Lead- Business Development

Trusted Partners

NONWOVENS_INDUSTRY
FB
issuewire
Financial_Express
logo_yourstory
FB

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

  • Order Placed (27 July, 2024)
  • Notify To Team (27 July, 2024)
  • Report updation (28 July, 2024)
  • Report Quality Check (28 July, 2024)
  • Report Dispatch (29 July, 2024)

  • paypal
  • icici
  • stripe
  • wire-transfer

  • Email
  • Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Recently Viewed Products

Logo

Global Plasma Fractionation Market Growth 2024-2030

Contact usWe are friendly and approachable, give us a call.

We uses Cookies

We use cookies to ensure you get the best experience on our website.